Achieving hepatitis C elimination in Europe - To treatment scale-up and beyond.
Hellard M, Scott N, Sacks-Davis R, Pedrana A
Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men.
Bradshaw D, Raghwani J, Jacka B, Sacks-Davis R, Lamoury F, Down I, Prestage G, Applegate TL, Hellard M, Sasadeusz J, Dore GJ, Pybus OG, Matthews GV, Danta M
The role of living context in prescription opioid injection and the associated risk of hepatitis C infection.
Sacks-Davis R, Daniel M, Roy É, Kestens Y, Zang G, Ramos Y, Hellard M, Jutras Aswad D, Bruneau J
Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local networks.
Hellard M, Sacks-Davis R, Doyle J
Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data.
Sacks-Davis R, McBryde E, Grebely J, Hellard M, Vickerman P
Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort.
Doyle JS, Deterding K, Grebely J, Wedemeyer H, Sacks-Davis R, Spelman T, Matthews G, Rice TM, Morris MD, McGovern BH, Kim AY, Bruneau J, Lloyd AR, Page K, Manns MP, Hellard ME, Dore GJ, InC3 Study Group